510(k) Report

FDA product code · Microbiology

Cytomegalovirus (Cmv) Dna Quantitative Assay

PABClass II21 CFR 866.3180510(k) required9 decisions since 20120 recalls

9 FDA decisions since 2012. 510(k) reviews decided 2021–2025 took a median of 88 days (half between 58 and 162). No recall names this code. The most-cited predicate is P210022, named by 1 later device.

Cytomegalovirus (CMV) DNA Quantitative Assay is an in vitro nucleic acid assay for the quantitative measurement of CMV DNA in human plasma. The assay can be used to measure CMV DNA levels serially at baseline and during the course of antiviral treatment to assess virological response to treatment. The test results must be interpreted within the context of all relevant clinical and laboratory findings.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, microbiology panel

Twenty years of PAB at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · PAB

3in 2025

2012: 32013: 102014: 42015: 82016: 72017: 132018: 242019: 212020: 82021: 42022: 92023: 142024: 162025: 3
2007high 24 (2018) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PAB

88in 2025

2025: 88 days median
2007high 88 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PAB

No recall names PAB since 2007.

Adverse event reports per year · PAB

4in 2025

2014: 12015: 22016: 12017: 12018: 22019: 12022: 12023: 32024: 22025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code PAB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20123—00
201310—00
20144—01
20158—02
20167—01
201713—01
201824—02
201921—01
20208—00
20214—00
20229—01
202314—03
202416—02
202538804
20260—0—
FIG. 1 — PAB by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in PAB? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report